Brief: VTv Therapeutics Got Into Second Amendment To License Agreement With Newsoara Biopharma Co
02/07/2024 21:45
July 2 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS: GOT INTO SECOND AMENDMENT TO LICENSE
AGREEMENT
WITH NEWSOARA BIOPHARMA CO
* VTV THERAPEUTICS: IN 2ND AMENDMENT, ON NEWSOARA PAYMENT OF
$20
MILLION UPFRONT FEE, ORIGINAL LICENSE TO BE EXPANDED TO GLOBAL
LICENSE
Source text for Eikon: ID:n0001641489-24-000054
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)